Impact of lipoprotein glomerulopathy on the relationship between lipids and renal diseases.
about
A case of lipoprotein glomerulopathy with thrombotic microangiopathy due to malignant hypertensionLipoprotein glomerulopathy treated with LDL-apheresis (Heparin-induced Extracorporeal Lipoprotein Precipitation system): a case report.Macrophage-derived apoESendai suppresses atherosclerosis while causing lipoprotein glomerulopathy in hyperlipidemic mice.Genetic analysis of intracapillary glomerular lipoprotein deposits in aging mice.Systemic and renal lipids in kidney disease development and progression.Lipoprotein glomerulopathy associated with a mutation in apolipoprotein eGlomerulopathy with homozygous apolipoprotein e2: a report of three cases and review of the literature.Glomerular diseases: genetic causes and future therapeutics.A possible structural basis behind the pathogenic role of apolipoprotein E hereditary mutations associated with lipoprotein glomerulopathy.Topics in lipoprotein glomerulopathy: an overview.Lipoprotein glomerulopathy in China.Apolipoprotein E mutations: a comparison between lipoprotein glomerulopathy and type III hyperlipoproteinemia.Five-year follow-up of a case of lipoprotein glomerulopathy with APOE Kyoto mutation.A Case of Lipoprotein Glomerulopathy with apoE Chicago and apoE (Glu3Lys) Treated with Fenofibrate.Long-term outcome of kidney transplantation in a patient with coexisting lipoprotein glomerulopathy and fibrillary glomerulonephritisA founder haplotype of APOE-Sendai mutation associated with lipoprotein glomerulopathy.The Novel Apolipoprotein E Mutation ApoE Chengdu (c.518T＞C, p.L173P) in a Chinese Patient with Lipoprotein Glomerulopathy.Scavenger receptor expressions in the kidneys of mice with lipoprotein glomerulopathy.Membranous Nephropathy-Like Apolipoprotein E Deposition Disease with Apolipoprotein E Toyonaka (Ser197Cys) and a Homozygous Apolipoprotein E2/2.
P2860
Q33406143-34C18D19-810F-4FB4-994B-BFDAE0EE5082Q33580086-F036D89E-2EF7-4096-8693-F50209AC9B39Q34238672-6C3480AD-A647-4461-90A6-69AF7F293F2AQ35374095-52249FCB-C3CA-41F0-B722-3A13ABB16D12Q37148885-CCA8F30F-BD04-4982-8FB8-598DB4E19A6AQ37384955-C080D267-CD8B-4E73-BF2F-6190797AD327Q37584745-A0DE8A79-B2B4-4506-9E28-CEAC522728FAQ37774243-22A67D30-B3D7-4C07-A8EC-355D7760A399Q38154771-2AF393BE-F8E9-4CF1-8D97-5D5EBB375C52Q38154772-00321A7F-6635-4F7C-ACB8-E41521F23775Q38156019-EA7F9821-A579-4305-A8A1-A52FD27423AFQ38191186-6EDED5E8-809D-435A-9F58-D6DF56E4BF4EQ42290046-ABFA8534-088F-4321-BC6D-26969C927ABBQ42365684-41D76431-0AFA-4292-8A95-39F2E1E9679CQ42676416-58D484E4-4A8D-403D-A9A8-E0B54EB39E88Q45172544-F5F601B1-E39E-4C35-866E-104452CBA114Q49339404-CDE99B42-C1FF-406D-B8C8-E76C58BDFC6EQ51390737-8D446858-1A61-4984-95CF-B441DA995339Q52564505-68EAA73A-1F62-4FA2-A262-23048201AA34
P2860
Impact of lipoprotein glomerulopathy on the relationship between lipids and renal diseases.
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Impact of lipoprotein glomerul ...... een lipids and renal diseases.
@ast
Impact of lipoprotein glomerul ...... een lipids and renal diseases.
@en
Impact of lipoprotein glomerul ...... een lipids and renal diseases.
@nl
type
label
Impact of lipoprotein glomerul ...... een lipids and renal diseases.
@ast
Impact of lipoprotein glomerul ...... een lipids and renal diseases.
@en
Impact of lipoprotein glomerul ...... een lipids and renal diseases.
@nl
prefLabel
Impact of lipoprotein glomerul ...... een lipids and renal diseases.
@ast
Impact of lipoprotein glomerul ...... een lipids and renal diseases.
@en
Impact of lipoprotein glomerul ...... een lipids and renal diseases.
@nl
P2093
P1476
Impact of lipoprotein glomerul ...... een lipids and renal diseases.
@en
P2093
Akira Matsunaga
Shinichi Oikawa
Takao Saito
P304
P356
10.1053/J.AJKD.2005.10.017
P577
2006-02-01T00:00:00Z